Anyone noticed the directors buying?
I wonder what is Andrew Kroger's endgame. He now has 25%. Will take him ages to do the creep at 3% per annum, so my main worry is private equity taking this away on the cheap. Heaps of cashflow, perfect candidate for PE to merge up with Cellcare, then hive off the blood cord operations separately and refloat the main business later on.
Anyone noticed the directors buying? I wonder what is Andrew...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CTE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
80.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.04M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1298 | 89.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 12037 | 1 |
View Market Depth
| Last trade - 16.12pm 01/10/2024 (20 minute delay) ? |
| CTE (ASX) Chart |
Day chart unavailable